Ewelina Tobiczyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ewelina Tobiczyk has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Szymon Skoczyński
Department of Lung Diseases and Tuberculosis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
4 shared publications Adam Barczyk
Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
3 shared publicationsAleksandra Oraczewska
Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
2 shared publicationsGrzegorz Brożek
Department of Epidemiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
2 shared publicationsKarolina Ficek
Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
2 shared publicationsKlaudia Glinka
Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland; 2(nd) Department of Lung Diseases and Tuberculosis, Medical University of Białystok, Poland
2 shared publications
Latest Publications
- 1 June 2025
- Published by Index Copernicus in Diagnostyka Laboratoryjna
- Vol. 61 (2) , 1-10
The significance of laboratory diagnostics in the monitoringof COVID-19 patients
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), brought significant strain to healthcare systems across the globe. In approximately 80% of cases,COVID-19 follows a mild course, typically presenting with symptoms of an upper respiratory tract viralinfection. However, the risk of severe illness increases in patients aged 60 and older, tobacco smokers, organtransplant recipients, and those with comorbidities such as obesity, cardiovascular disease, chronic kidneydisease, diabetes, chronic lung disease, and cancer. In severe cases, patients may develop respiratory failure,septic shock, and/or multiple organ dysfunction. Laboratory blood testing is essential to evaluating theseverity of infection and monitoring the patient’s clinical status. Due to the risk of respiratory failure, evaluatingacid-base balance through arterial blood gas analysis upon hospital admission and continuing to monitor itduring hospitalisation helps guide proper oxygen therapy. Early detection of metabolic abnormalities helpsin selecting appropriate therapeutic interventions and improves patient prognosis. SARS-CoV-2 infection canlead to sepsis and multi-organ dysfunction. To monitor these complications, clinicians rely on laboratory tests.Although the observed abnormalities are not specific to COVID-19 and may occur in other illnesses, lab testingremains a readily available and reliable method for monitoring the progression of COVID-19 and its associatedorgan complications. These tests also play a crucial role in prognosis and in evaluating disease severity.
- 1 June 2025
- Published by Index Copernicus in Diagnostyka Laboratoryjna
- Vol. 61 (2) , 1-10
The significance of laboratory diagnostics in the monitoringof COVID-19 patients
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), brought significant strain to healthcare systems across the globe. In approximately 80% of cases,COVID-19 follows a mild course, typically presenting with symptoms of an upper respiratory tract viralinfection. However, the risk of severe illness increases in patients aged 60 and older, tobacco smokers, organtransplant recipients, and those with comorbidities such as obesity, cardiovascular disease, chronic kidneydisease, diabetes, chronic lung disease, and cancer. In severe cases, patients may develop respiratory failure,septic shock, and/or multiple organ dysfunction. Laboratory blood testing is essential to evaluating theseverity of infection and monitoring the patient’s clinical status. Due to the risk of respiratory failure, evaluatingacid-base balance through arterial blood gas analysis upon hospital admission and continuing to monitor itduring hospitalisation helps guide proper oxygen therapy. Early detection of metabolic abnormalities helpsin selecting appropriate therapeutic interventions and improves patient prognosis. SARS-CoV-2 infection canlead to sepsis and multi-organ dysfunction. To monitor these complications, clinicians rely on laboratory tests.Although the observed abnormalities are not specific to COVID-19 and may occur in other illnesses, lab testingremains a readily available and reliable method for monitoring the progression of COVID-19 and its associatedorgan complications. These tests also play a crucial role in prognosis and in evaluating disease severity.
- Open Access
- 18 July 2019
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 7 (3) , 303-310
May Dyspnea Sensation Influence the Sexual Function in Men With Obstructive Sleep Apnea Syndrome? A Prospective Control Study
Introduction: Dyspnea sensation is frequently present in obstructive sleep apnea syndrome (OSA) patients; however, its possible influence on sexual function and body image has not been well analyzed. Aims: To evaluate sexual function, the prevalence of sexual dysfunction (SD), and body image during sexual activity and its relationship with dyspnea in men with OSA. Methods: 129 men were included in the prospective study, with 61 diagnosed with OSA (cases) and 68 age- and BMI-matched healthy control subjects. Patients were assessed for the severity of heart failure by the New York Heart Association scale and dyspnea by the Visual Analogue Scale. OSA was confirmed by in-laboratory polysomnography. Main Outcome Measures: International Index of Erectile Function (IIEF) was used as a measure of sexual function, body image during sexual activity was assessed by the Body Exposure During Sexual Activity Questionnaire, whereas SD was diagnosed using criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Results: The mean age of the studied population was 57.9 ± 10.8 years. Presence of dyspnea interfered with sexual life in 20% of men diagnosed with OSA and with work performance in 33%. Men with OSA had worse scores in IIEF-15 compared with control subjects and higher frequency of sexual distress compared with men with OSA. There were no differences in the rate of SD according to criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. The presence of OSA worsened the perceived body image during sexual activity. The presence of dyspnea was the only negative factor affecting sexual function in general (IIEF-15 score) and 1 of the factors affecting erectile function and orgasmic function. Conclusion: In men with OSA, body image is negatively influenced by the presence of OSA. Furthermore, the presence of dyspnea assessed by the New York Heart Association scale impairs sexual function in that group of men.
- 18 July 2019
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 7 (3) , 303-310
Open AccessMay Dyspnea Sensation Influence the Sexual Function in Men With Obstructive Sleep Apnea Syndrome? A Prospective Control Study
Introduction: Dyspnea sensation is frequently present in obstructive sleep apnea syndrome (OSA) patients; however, its possible influence on sexual function and body image has not been well analyzed. Aims: To evaluate sexual function, the prevalence of sexual dysfunction (SD), and body image during sexual activity and its relationship with dyspnea in men with OSA. Methods: 129 men were included in the prospective study, with 61 diagnosed with OSA (cases) and 68 age- and BMI-matched healthy control subjects. Patients were assessed for the severity of heart failure by the New York Heart Association scale and dyspnea by the Visual Analogue Scale. OSA was confirmed by in-laboratory polysomnography. Main Outcome Measures: International Index of Erectile Function (IIEF) was used as a measure of sexual function, body image during sexual activity was assessed by the Body Exposure During Sexual Activity Questionnaire, whereas SD was diagnosed using criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Results: The mean age of the studied population was 57.9 ± 10.8 years. Presence of dyspnea interfered with sexual life in 20% of men diagnosed with OSA and with work performance in 33%. Men with OSA had worse scores in IIEF-15 compared with control subjects and higher frequency of sexual distress compared with men with OSA. There were no differences in the rate of SD according to criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. The presence of OSA worsened the perceived body image during sexual activity. The presence of dyspnea was the only negative factor affecting sexual function in general (IIEF-15 score) and 1 of the factors affecting erectile function and orgasmic function. Conclusion: In men with OSA, body image is negatively influenced by the presence of OSA. Furthermore, the presence of dyspnea assessed by the New York Heart Association scale impairs sexual function in that group of men.
- 3 May 2019
- Published by Springer Nature
- Vol. 1160, 19-23
Chronic Obstructive Pulmonary Disease and Platelet Count
Recently, it has been shown in the murine model that platelet maturation takes place, to some extent, in the lungs. The extrapolation of these findings to humans leads to the possibility that chronic lung diseases could affect platelet maturation and, consequently, the platelet count. The aim of this study was to investigate whether there are changes in the platelet count in patients with chronic obstructive disease (COPD). The study included 44 patients, aged 66.5 ± 5.5 years, in stage II-IV COPD. The control group consisted of 48 age- and gender-matched patients without any respiratory diseases. We failed to find a significant difference in the platelet count between the two groups: 231 ± 80 vs. 223 ± 63 x 103/μL, respectively (p = 0.61). However, the number of platelets in the COPD patients was inversely associated with hemoglobin content (r = −0.57; p < 0.001), hematocrit (r = −0.40; p = 0.006), and the red cell count (r = −0.51; p < 0.001); the blood morphology indices that are typically increased in severe COPD. Such associations were absent in the control non-COPD group. We conclude that COPD has no influence on the platelet count in humans.
- 3 May 2019
- Published by Springer Nature
- Vol. 1160, 19-23
Chronic Obstructive Pulmonary Disease and Platelet Count
Recently, it has been shown in the murine model that platelet maturation takes place, to some extent, in the lungs. The extrapolation of these findings to humans leads to the possibility that chronic lung diseases could affect platelet maturation and, consequently, the platelet count. The aim of this study was to investigate whether there are changes in the platelet count in patients with chronic obstructive disease (COPD). The study included 44 patients, aged 66.5 ± 5.5 years, in stage II-IV COPD. The control group consisted of 48 age- and gender-matched patients without any respiratory diseases. We failed to find a significant difference in the platelet count between the two groups: 231 ± 80 vs. 223 ± 63 x 103/μL, respectively (p = 0.61). However, the number of platelets in the COPD patients was inversely associated with hemoglobin content (r = −0.57; p < 0.001), hematocrit (r = −0.40; p = 0.006), and the red cell count (r = −0.51; p < 0.001); the blood morphology indices that are typically increased in severe COPD. Such associations were absent in the control non-COPD group. We conclude that COPD has no influence on the platelet count in humans.
- 16 April 2019
- Published by Springer Nature
- Vol. 1160, 53-64
Noninvasive Ventilation-Facilitated Bronchofiberoscopy in Patients with Respiratory Failure
Respiratory failure is one of the most important risk factors for diagnostic bronchofiberoscopy (BF), whereas therapeutic bronchoscopies are typically performed in intubated patients. Only a few published studies analyzed the outcomes of noninvasive mechanical ventilation (NIV)-facilitated BF. In this case series, we present our experiences with NIV-facilitated diagnostic and therapeutic BF performed in patients with respiratory failure that was associated with acute interstitial pulmonary disease, chronic obstructive pulmonary disease, cystic fibrosis exacerbation, foreign body aspiration, tracheal stenosis, pneumonia, and in a patient with a neuromuscular disease. All of the patients were initially hypoxic and some had PaO2/FiO2 < 200, which corresponded to moderate-to-acute respiratory distress syndrome (ARDS). NIV-facilitated BF were performed for the diagnostic or therapeutic purposes. The former consisted of bronchoalveolar lavage and bacterial sampling in a patient with impaired cough reflex, airway assessment in otherwise unexplained respiratory failure and hemoptysis, and the latter of mucous plugs resolution, foreign body removal, and assistance in weaning from mechanical ventilation. All procedures were carried out using NIV in the spontaneous timed (ST) or average volume assured pressure support (AVAPS) mode with oxygen supplementation. There were no procedure-related complications noticed during NIV-facilitated BF. We conclude that NIV is a useful and safe tool that facilitates the performance of BF in severe pulmonary diseases. Prospective studies are required to set the recommendations for the procedure and to define the optimum ventilatory modes to be used.
- 16 April 2019
- Published by Springer Nature
- Vol. 1160, 53-64
Noninvasive Ventilation-Facilitated Bronchofiberoscopy in Patients with Respiratory Failure
Respiratory failure is one of the most important risk factors for diagnostic bronchofiberoscopy (BF), whereas therapeutic bronchoscopies are typically performed in intubated patients. Only a few published studies analyzed the outcomes of noninvasive mechanical ventilation (NIV)-facilitated BF. In this case series, we present our experiences with NIV-facilitated diagnostic and therapeutic BF performed in patients with respiratory failure that was associated with acute interstitial pulmonary disease, chronic obstructive pulmonary disease, cystic fibrosis exacerbation, foreign body aspiration, tracheal stenosis, pneumonia, and in a patient with a neuromuscular disease. All of the patients were initially hypoxic and some had PaO2/FiO2 < 200, which corresponded to moderate-to-acute respiratory distress syndrome (ARDS). NIV-facilitated BF were performed for the diagnostic or therapeutic purposes. The former consisted of bronchoalveolar lavage and bacterial sampling in a patient with impaired cough reflex, airway assessment in otherwise unexplained respiratory failure and hemoptysis, and the latter of mucous plugs resolution, foreign body removal, and assistance in weaning from mechanical ventilation. All procedures were carried out using NIV in the spontaneous timed (ST) or average volume assured pressure support (AVAPS) mode with oxygen supplementation. There were no procedure-related complications noticed during NIV-facilitated BF. We conclude that NIV is a useful and safe tool that facilitates the performance of BF in severe pulmonary diseases. Prospective studies are required to set the recommendations for the procedure and to define the optimum ventilatory modes to be used.